February 2019
”... knowledge graphs exemplify the linked data approach underpinning the growing adoption of JSON-LD — and the demonstrable, recurring business value that linked data consistently provides.” via @Forbes forbes.com/sites/forbeste…
”All too often I am met with surprise when I tell patient groups that clinical trials are designed to answer just a single fundamental question. They rightfully expect that their data will live on and be used to help solve future problems.” twitter.com/VivliCenter/st…
’In an age of breathless enthusiasm for the new and “disruptive,” it’s worth remembering the mundane agreements embodied in the things around us.’ nyti.ms/2V1L4Cs
”A unique and key feature of RDF is that it is perfectly suited to link and moderate between different data schemas, conceptual/data granularity levels or data management systems” @SoerenAuer linkedin.com/pulse/cognitiv…
@NovasTaylor @iamnotthelotus @JAertsXML4Pharm Yes, my understanding as well. And I think it is in general better that the RDF version is created by the originator slideshare.net/kerfors/pushin… (presentation from 2013, so it takes a loooong time to get there :(
yes, a lot of 'loculated data' when looking across metadata describing clinical trials and data. However, I don't think the mantra 'If just everyone 'followed The Standard' we would be good", is the (only) answer. (Maybe a topic for a blog post of mine??) twitter.com/kerfors/status…
”What really seems to drive sophisticated data scientists crazy about pharma is the loculated nature of the data, the fact that the data associated with each project and each step seem to exist in their own universe.” @DShaywitz forbes.com/sites/davidsha…
Once again I am linking to @DShaywitz's great article with @VasNarasimhan forbes.com/sites/davidsha…